Herbas VPB

Print
EN | LT
LT - 2,4-Diaminochinazolino dariniai ir jų naudojimas virusinės infekcijos, vėžio ir alergijų gydymui
EN - 2,4-DIAMINOQUINAZOLINE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF VIRUS INFECTIONS, CANCER OR ALLERGIES

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 239/95 (2006.01)
A61K 31/517 (2006.01)
A61P 1/16 (2006.01)
A61P 37/06 (2006.01)
A61P 35/00 (2006.01)
A61P 31/12 (2006.01)
European patent
(11) Number of the document 3759083
(13) Kind of document T
(96) European patent application number 19708817.2
Date of filing the European patent application 2019-02-28
(97) Date of publication of the European application 2021-01-06
(45) Date of publication and mention of the grant of the patent 2022-05-04
(46) Date of publication of the claims translation 2022-07-11
PCT application
(86) Number PCT/EP2019/054941
Date 2019-02-28
PCT application publication
(87) Number WO 2019/166532
Date 2019-09-06
Priority applications
(30) Number Date Country code
18159583 2018-03-01 EP
Inventors
(72)
MC GOWAN, David, Craig , BE
EMBRECHTS, Werner, Constant, Johan , BE
GUILLEMONT, Jérôme, Émile, Georges , FR
COOYMANS, Ludwig, Paul , BE
JONCKERS, Tim, Hugo, Maria , BE
RABOISSON, Pierre, Jean-Marie, Bernard , BE
Grantee
(73) Janssen Sciences Ireland Unlimited Company , Barnahely, Ringaskiddy, Co Cork, IE
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) 2,4-Diaminochinazolino dariniai ir jų naudojimas virusinės infekcijos, vėžio ir alergijų gydymui
  2,4-DIAMINOQUINAZOLINE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF VIRUS INFECTIONS, CANCER OR ALLERGIES
Last renewal fee
Payment date Validity (years) Amount
2024-01-30 6 139.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2025-02-28